Phase II Clinical Trial of the Radioactive Strontium(89Sr) Chloride Agent, SMS. 2P for Pain Palliation in Patients with Prostate Cancer with Bone Metastases.
PECHER, C. Biological investigations with radioactive calcium and strontium: preliminary report on the use of radioactive strontium in treatment of metastatic bone cancer. Pharmacol. 1942, 11, 117-149
ROBINSON, RG. Treatment of metastatic bone pain with strontium-89. Nucl Med Biol. 1987, 14, 219-222